| 000 | 01756 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515050956.0 | ||
| 264 | 0 | _c20070529 | |
| 008 | 200705s 0 0 eng d | ||
| 022 | _a1360-9947 | ||
| 024 | 7 |
_a10.1093/molehr/gal104 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHiga, R | |
| 245 | 0 | 0 |
_aPPARdelta and its activator PGI2 are reduced in diabetic embryopathy: involvement of PPARdelta activation in lipid metabolic and signalling pathways in rat embryo early organogenesis. _h[electronic resource] |
| 260 |
_bMolecular human reproduction _cFeb 2007 |
||
| 300 |
_a103-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xembryology |
| 650 | 0 | 4 |
_aDinoprostone _xanalysis |
| 650 | 0 | 4 | _aEmbryo Culture Techniques |
| 650 | 0 | 4 |
_aEmbryo, Mammalian _xanatomy & histology |
| 650 | 0 | 4 |
_aEpoprostenol _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFetal Development _xdrug effects |
| 650 | 0 | 4 |
_aFetal Diseases _xchemically induced |
| 650 | 0 | 4 |
_aLipid Metabolism _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOrganogenesis |
| 650 | 0 | 4 |
_aPPAR delta _xmetabolism |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPregnancy in Diabetics |
| 650 | 0 | 4 | _aPregnancy, Animal |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aStreptozocin |
| 700 | 1 | _aGonzález, E | |
| 700 | 1 | _aPustovrh, M C | |
| 700 | 1 | _aWhite, V | |
| 700 | 1 | _aCapobianco, E | |
| 700 | 1 | _aMartínez, N | |
| 700 | 1 | _aJawerbaum, A | |
| 773 | 0 |
_tMolecular human reproduction _gvol. 13 _gno. 2 _gp. 103-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/molehr/gal104 _zAvailable from publisher's website |
| 999 |
_c16718267 _d16718267 |
||